CTNNB1 and hepatocellular carcinoma: Among the potential target genes analyzed, the β-catenin gene, CTNNB1, was chosen for further experimental validation (Figure 5A), mainly because it is co-transcription factor in the Wnt/β-catenin signaling pathway, which has a significant role in HCC development and progression.